BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 22, 2016
View Archived Issues
New variant detected in SIX3 gene in patient with holoprosencephaly
Read More
AstraZeneca provide early data on AZD-7594
Read More
ThromboGenics and Galapagos sign global and exclusive in-licensing agreement
Read More
Qu Biologics presents initial results from QBECO-01 trial
Read More
Phase III study of pegvaliase for treatment of PKU meets primary endpoint
Read More
FDA first to approve Anthim for inhalation anthrax
Read More
Theratechnologies and TaiMed Biologics sign exclusive agreement for ibalizumab
Read More
AVEO and CANbridge enter exclusive licensing agreement for AV-203 outside of North America
Read More
Oncolix initiates first-in-human study of Prolanta for ovarian cancer
Read More
Lupin announces MAP kinase inhibitors
Read More
First-in-human study explores ARX-788 for advanced breast cancer
Read More
Delta-Fly initiates phase I trial of DFP-13318 in advanced solid tumors
Read More
Transgenomic launches EGFR C797S mutation detector assay
Read More
Harvard University and Merck & Co. announce collaboration agreement to develop cancer therapeutics
Read More
Idelvion now available in U.S.
Read More
ContraVir initiates phase I/IIa trial of CMX-157 in chronic HBV infection
Read More
Evotec announces spin-off company Topas Therapeutics
Read More
FDA approves use of Roche's HCV RNA test to aid diagnosis of active HCV infection
Read More
Janssen and Genentech enter clinical trial collaboration to study daratumumab with atezolizumab
Read More
Biocept collaborates on trial to analyze biomarkers
Read More
Moberg announces phase III plans and agreement with Cadila for BUPI
Read More
Synairgen reports promising in vitro findings from LOXL2 inhibitor program for IPF
Read More
NCC, University of Tokyo and Daiichi Sankyo collaborate in malignant lymphoma research
Read More
TCTE3 shows potential as a biomarker for the diagnosis of pancreatobiliary tumors
Read More